Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology

被引:121
|
作者
Hehir, Michael K. [1 ]
Silvestri, Nicholas J. [2 ]
机构
[1] Univ Vermont, Larner Coll Med, Dept Neurosci, 1 South Prospect St, Burlington, VT 05401 USA
[2] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, 1010 Main St, Buffalo, NY 14202 USA
关键词
Myasthenia gravis; Acetylcholine receptor; Antimuscle-specific kinase; Occular; RYANODINE RECEPTOR ANTIBODIES; DIAGNOSIS; AUTOANTIBODIES; CHILDHOOD; RITUXIMAB; MANAGEMENT; CHILDREN; FEATURES; TRIAL;
D O I
10.1016/j.ncl.2018.01.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myasthenia gravis (MG) is a rare disease but the most common disorder of the neuromuscular junction. It is the prototypic autoimmune disease most commonly caused by antibodies to the acetylcholine receptor (AChR) leading to characteristic fatigable weakness of the ocular, bulbar, respiratory, axial, and limb muscles. The majority of patients with MG first present with ocular symptoms. Most patients with MG experience at least 1 exacerbation of symptoms throughout the course of their illness. This article covers the epidemiology, clinical presentation, classification, and natural history of MG.
引用
收藏
页码:253 / +
页数:9
相关论文
共 50 条
  • [31] Clinical outcome of generalized myasthenia gravis in Hong Kong Chinese
    Lee, C. Y.
    Lam, C. L.
    Pang, S. Y. Y.
    Lau, K. K.
    Teo, K. C.
    Chang, R. S. K.
    Chan, K. H.
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 289 : 177 - 181
  • [32] A SYSTEMATIC REVIEW OF MYASTHENIA GRAVIS EPIDEMIOLOGY
    Fitzpatrick, A. S.
    Cardwell, C.
    McCarron, C.
    McConville, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
  • [33] Subgroup Classification of Myasthenia Gravis
    Renjen, Pushpendra N.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2021, 24 (02)
  • [34] Epidemiology of myasthenia gravis in northwestern Sardinia
    Aiello, I
    Pastorino, N
    Sotgiu, S
    Pirastru, MI
    Sau, GF
    Sanna, G
    Rosati, G
    NEUROEPIDEMIOLOGY, 1997, 16 (04) : 199 - 206
  • [35] Epidemiology of seropositive myasthenia gravis in Greece
    Poulas, K
    Tsibri, E
    Kokla, A
    Papanastasiou, D
    Tsouloufis, T
    Marinou, M
    Tsantili, P
    Papapetropoulos, T
    Tzartos, SJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 (03): : 352 - 356
  • [36] EPIDEMIOLOGY OF MYASTHENIA-GRAVIS IN NORWAY
    STORMMATHISEN, A
    ACTA NEUROLOGICA SCANDINAVICA, 1984, 70 (04): : 274 - 284
  • [37] Epidemiology of Autoimmune Myasthenia Gravis in Argentina
    Mazia, C. G.
    Melcom, M. O.
    Salutto, V. L.
    JOURNAL OF NEUROLOGY, 2012, 259 : S208 - S209
  • [38] Epidemiology of myasthenia gravis in Ontario, Canada
    Breiner, Ari
    Widdifield, Jessica
    Katzberg, Hans D.
    Barnett, Carolina
    Bril, Vera
    Tu, Karen
    NEUROMUSCULAR DISORDERS, 2016, 26 (01) : 41 - 46
  • [39] Epidemiology of myasthenia gravis in the United States
    Ye, Yun
    Murdock, Dana Jorgensen
    Chen, Chao
    Liedtke, Wolfgang
    Knox, Caitlin A.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [40] Insights into the Classification of Myasthenia Gravis
    Akaishi, Tetsuya
    Yamaguchi, Takuhiro
    Suzuki, Yasushi
    Nagane, Yuriko
    Suzuki, Shigeaki
    Murai, Hiroyuki
    Imai, Tomihiro
    Motomura, Masakatsu
    Fujihara, Kazuo
    Aoki, Masashi
    Utsugisawa, Kimiaki
    PLOS ONE, 2014, 9 (09):